Rx data firms sue Maine, Vermont

Share this article:
Three firms are challenging Maine and Vermont over new state laws that restrict the collection and disclosure of physician prescribing information.

IMS Health, Wolters Kluwer Health and Verispan want to prevent statutes in the two states from taking effect Jan. 1.

A similar New Hampshire law that would have limited drug company access to doctors' prescribing habits was struck down in U.S. District Court in April on constitutional grounds. That ruling is under appeal.

The suits, filed in late August, say the Maine and Vermont statutes differ only slightly from the New Hampshire law and that they deny access to information that is central to improving the quality of care and ensuring patient safety.

But Vermont and Maine officials said that after the New Hampshire ruling, they altered their laws and would fight the lawsuit. “We will vigorously defend the constitutionality of the law and oppose efforts to have its enforcement enjoined,” Maine's attorney general told the AP.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

New lipid agents are high on potency, low on doc awareness

New lipid agents are high on potency, low ...

The new PCSK9 class of cholesterol-lowering antibodies continues to look promising, but many doctors—particularly PCPs—have never even heard of the experimental drugs.

Novartis may have game-changing drug

Novartis may have game-changing drug

Key opinion leaders indicate they are ready to embrace Novartis's experimental heart failure medication LCZ696. Such a move could upend heart failure treatment protocols.

Five things for pharma marketers to know: Tuesday, September 2

Five things for pharma marketers to know: Tuesday, ...

Sanofi and Regeneron unveil Phase-III results of their PCSK9; Merck will present data on its anti-PD-1 at the end of this month; WSJ op/ed suggests US should lead fight against ...